Stay updated on Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The site's footer revision label changed from v3.7.0 to v3.7.1, while the page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-13T23:40:24.000Z thumbnail image
  2. Check
    15 days ago
    No Change Detected
  3. Check
    22 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the usual study details with an error screen. A Home button is provided to navigate away from the blocked page.
    Difference
    21%
    Check dated 2026-09-23T00:51:41.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Revision number updated from v3.6.6 to v3.7.0, indicating a new page version and routine maintenance. This change does not modify study content, eligibility criteria, or any user-facing information on the page.
    Difference
    0.0%
    Check dated 2026-09-16T00:08:20.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.5 to v3.6.6, indicating a minor update to the Study Details page. This reflects a page metadata revision rather than modifications to the study data or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-09-01T19:31:59.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.4 to v3.6.5, indicating a newer release of the study details page. The visible content remains unchanged; the change reflects an internal version update.
    Difference
    0.0%
    Check dated 2026-08-11T18:02:40.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    The page's revision history now shows a new version, v3.6.4, superseding the previous v3.6.3. This indicates a backend/content update to the page rather than changes to the study details or results.
    Difference
    0.0%
    Check dated 2026-07-28T14:58:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+Cabozantinib in Metastatic Renal Cell Carcinoma Clinical Trial page.